Enovix (ENVX) opened Q1 2026 with revenue of US$7.6 million and a basic EPS loss of US$0.18, alongside a net loss of US$38.26 million. On a trailing 12 month basis, the company generated US$34.32 million of revenue and a basic EPS loss of US$0.81 tied to a US$171.49 million net loss. Over recent quarters, the company has seen revenue range from US$5.10 million to US$11.27 million with quarterly basic EPS losses between US$0.12 and US$0.26. This provides a clear view of how growth and losses have been moving together. For investors, the story this quarter is about balancing that expanding top line against still heavy losses and compressed margins.

See our full analysis for Enovix.

With the headline numbers on the table, the next step is to see how this mix of growth and losses lines up against the key narratives that have built up around Enovix over the past year.

TTM losses of US$171 million frame the profitability challenge

• On a trailing 12 month basis, Enovix reported revenue of US$34.3 million against a net loss of US$171.5 million and a basic EPS loss of US$0.81, so the business is still very much in spending mode to support its battery roll out.
• Consensus narrative talks about future revenue growth toward US$432.3 million and earnings of US$50.1 million. However, the current trailing loss of US$171.5 million and EPS loss of US$0.81 show that any path toward those figures would need a sizeable swing in profitability.
  • Analysts also flag that losses have grown at around 20.2% per year over the past five years, which contrasts with the idea of earnings reaching US$50.1 million without a clear shift in the cost base yet.
  • With the stock at US$6.30 versus an analyst target of US$13.10, you are being asked to weigh that potential upside against the reality of the current loss profile.

Fast revenue run rate meets bearish concerns on losses

• Over the last 12 months, revenue of US$34.3 million has come with a net loss of US$171.5 million, and models expect earnings to decline by an average of 4.5% per year over the next three years while the company remains unprofitable.
• Bears focus on that combination of strong top line and ongoing losses, and the latest numbers give them fresh material to point to.
  • They highlight that even with revenue forecast to grow about 57.4% per year, there is no profitability projected within three years and historical losses have risen at roughly 20.2% a year.
  • That backdrop, together with forecast earnings declines, supports the cautious view that revenue growth on its own may not quickly translate into positive EPS or net income.

On top of these results, skeptics point out that the path from a US$171.5 million trailing loss to sustained profitability is still unclear, so it helps to read how they build that case in context of customer ramp timing and factory scale out. 🐻 Enovix Bear Case

39x P/S vs peers puts pressure on the bullish case

• The stock is trading on a P/S of 39x, compared with about 14.4x for peers and 2.8x for the broader US Electrical industry, so investors are paying a much higher multiple for Enovix’s US$34.3 million of trailing revenue.
• Bulls argue that potential smartphone, smart eyewear and defense wins justify paying up, and the current numbers partly line up with that argument but also set a high bar.
  • The bullish narrative leans on very strong forecast revenue growth and a possible move toward industry like margins. Yet today the company is still reporting a trailing net loss of US$171.5 million and an EPS loss of US$0.81.
  • With the share price at US$6.30 and an analyst target of US$13.10, the premium P/S multiple means that a lot of that future growth story is already reflected in the valuation.

If you want to see how bullish investors connect these growth projects to valuation, it is worth reading their full case around smartphone, AR and defense ramp assumptions in one place. 🐂 Enovix Bull Case

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Enovix on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

With bullish and bearish narratives pulling in different directions, now is the time to look through the numbers yourself and decide what matters most. To see how the current story balances potential upside with the key issues raised by cautious investors, review the 1 key reward and 2 important warning signs.

See What Else Is Out There

Enovix combines a trailing 12 month net loss of US$171.5 million with a 39x P/S ratio, so profitability and valuation risk remain key concerns.

If you want stocks where those pressures are lower, compare this profile with companies in the 67 resilient stocks with low risk scores to quickly focus on businesses with more resilient risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.